Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126263171 | 12626317 | 1 | I | 20070906 | 20080219 | 20160805 | 20160805 | EXP | GB-ASTELLAS-2008000364 | ASTELLAS | 78.83 | YR | M | Y | 0.00000 | 20160805 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126263171 | 12626317 | 1 | PS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | UNK UNK, UNKNOWN FREQ. | Y | 0 | FORMULATION UNKNOWN | ||||||||
| 126263171 | 12626317 | 2 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | U | 0 | 1 | DF | FORMULATION UNKNOWN | QD | ||||||
| 126263171 | 12626317 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | 20 | MG | CAPSULE | |||||||
| 126263171 | 12626317 | 4 | C | EPADERM | MINERAL OILPETROLATUMWAX, EMULSIFYING | 1 | Oral | U | 0 | 500 | MG | OINTMENT | |||||||
| 126263171 | 12626317 | 5 | C | CARDIOPIRIN | ASPIRIN | 1 | Oral | UNK UNK, UNKNOWN FREQ. | U | 0 | MODIFIED-RELEASE TABLET | ||||||||
| 126263171 | 12626317 | 6 | C | ASPIRIN DISPERSIDE | 2 | Oral | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | |||||||||
| 126263171 | 12626317 | 7 | C | CO CODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | 30/500 MG, UNKNOWN FREQ. | U | 0 | TABLET | ||||||||
| 126263171 | 12626317 | 8 | C | ISORBIDE | ISOSORBIDE | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126263171 | 12626317 | 9 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Oral | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN | ||||||||
| 126263171 | 12626317 | 10 | C | INTAL | CROMOLYN SODIUM | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | EYE DROPS | ||||||||
| 126263171 | 12626317 | 11 | C | Atorvastatin | ATORVASTATIN | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | U | 0 | FORMULATION UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126263171 | 12626317 | 1 | Non-small cell lung cancer |
| 126263171 | 12626317 | 3 | Product used for unknown indication |
| 126263171 | 12626317 | 4 | Product used for unknown indication |
| 126263171 | 12626317 | 5 | Product used for unknown indication |
| 126263171 | 12626317 | 6 | Product used for unknown indication |
| 126263171 | 12626317 | 7 | Product used for unknown indication |
| 126263171 | 12626317 | 8 | Product used for unknown indication |
| 126263171 | 12626317 | 9 | Product used for unknown indication |
| 126263171 | 12626317 | 10 | Product used for unknown indication |
| 126263171 | 12626317 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126263171 | 12626317 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126263171 | 12626317 | Anaemia | |
| 126263171 | 12626317 | Diarrhoea | |
| 126263171 | 12626317 | Hypercalcaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126263171 | 12626317 | 1 | 20070718 | 0 | ||
| 126263171 | 12626317 | 4 | 20070502 | 0 | ||
| 126263171 | 12626317 | 5 | 20070430 | 0 | ||
| 126263171 | 12626317 | 6 | 20070430 | 0 | ||
| 126263171 | 12626317 | 7 | 20070502 | 0 | ||
| 126263171 | 12626317 | 9 | 20070530 | 0 | ||
| 126263171 | 12626317 | 10 | 20070530 | 0 | ||
| 126263171 | 12626317 | 11 | 20070430 | 0 |